Stocks didn't budge after the Federal Reserve opted to keep interest rates steady on Wednesday. The central bank voted 10-2 to keep the federal funds rate in a target range of 3.75% to 4%. The Dow ...
A lot has changed in a short amount of time. Many officials at the September meeting found financial conditions to be ...
Follow live coverage of the Federal Reserve's October meeting, interest-rate decision, and Chair Kevin Warsh's press ...
Good morning and the day of reckoning for markets has arrived as megacap tech players join the earnings party and the Fed ...
After a unanimous decision to increase interest rates in September, the Fed was more divided in October. Cleveland Fed ...
Micron Technology MU +2.77% just got a great signal from one of its key rivals. Shares were climbing after South Korea’s SK Hynix 000660 +10.89% reported blockbuster earnings and said memory-chip ...
Flex stock rises after the company hikes its guidance. The business outlook might say more about Flex’s upcoming spinoff than ...
GSK beat earnings estimates handily, but suffered soft vaccine sales. The biopharma is moving quickly to bring new medicines ...
Sidecar” transformers from the likes of Vertiv and Eaton help keep servers safe as data centers grow more powerful. Why the ...
The Fed’s decision to keep rates unchanged Wednesday—after raising them in September—gives policymakers some breathing room ...
Julie Sweet snapped up 12,200 shares of the large consulting company at an average price of about $246. The stock’s June 30 ...
Genmab scores a ‘hat trick’ with positive data for its experimental cancer drug, petosemtamab, Jefferies says.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results